Advertisement
Research Article

Potential Downstream Target Genes of Aberrant ETS Transcription Factors Are Differentially Affected in Ewing’s Sarcoma and Prostate Carcinoma

  • Maria J. Camões equal contributor,

    equal contributor Contributed equally to this work with: Maria J. Camões, Paula Paulo

    Affiliations: Department of Genetics, Portuguese Oncology Institute-Porto, Porto, Portugal, Cancer Genetics Group, Research Centre of the Portuguese Oncology Institute-Porto, Porto, Portugal

    X
  • Paula Paulo equal contributor,

    equal contributor Contributed equally to this work with: Maria J. Camões, Paula Paulo

    Affiliations: Department of Genetics, Portuguese Oncology Institute-Porto, Porto, Portugal, Cancer Genetics Group, Research Centre of the Portuguese Oncology Institute-Porto, Porto, Portugal

    X
  • Franclim R. Ribeiro,

    Affiliations: Department of Genetics, Portuguese Oncology Institute-Porto, Porto, Portugal, Cancer Genetics Group, Research Centre of the Portuguese Oncology Institute-Porto, Porto, Portugal

    X
  • João D. Barros-Silva,

    Affiliations: Department of Genetics, Portuguese Oncology Institute-Porto, Porto, Portugal, Cancer Genetics Group, Research Centre of the Portuguese Oncology Institute-Porto, Porto, Portugal

    X
  • Mafalda Almeida,

    Affiliations: Department of Genetics, Portuguese Oncology Institute-Porto, Porto, Portugal, Cancer Epigenetics Group, Research Centre of The Portuguese Oncology Institute, Porto, Portugal

    X
  • Vera L. Costa,

    Affiliations: Department of Genetics, Portuguese Oncology Institute-Porto, Porto, Portugal, Cancer Epigenetics Group, Research Centre of The Portuguese Oncology Institute, Porto, Portugal

    X
  • Nuno Cerveira,

    Affiliations: Department of Genetics, Portuguese Oncology Institute-Porto, Porto, Portugal, Cancer Genetics Group, Research Centre of the Portuguese Oncology Institute-Porto, Porto, Portugal

    X
  • Rolf I. Skotheim,

    Affiliations: Department of Cancer Prevention, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway, Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway

    X
  • Ragnhild A. Lothe,

    Affiliations: Department of Cancer Prevention, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway, Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway

    X
  • Rui Henrique,

    Affiliations: Cancer Epigenetics Group, Research Centre of The Portuguese Oncology Institute, Porto, Portugal, Department of Pathology, Portuguese Oncology Institute-Porto, Porto, Portugal, Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, Porto, Portugal

    X
  • Carmen Jerónimo,

    Affiliations: Department of Genetics, Portuguese Oncology Institute-Porto, Porto, Portugal, Cancer Epigenetics Group, Research Centre of The Portuguese Oncology Institute, Porto, Portugal, Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, Porto, Portugal

    X
  • Manuel R. Teixeira mail

    manuel.teixeira@ipoporto.min-saude.pt

    Affiliations: Department of Genetics, Portuguese Oncology Institute-Porto, Porto, Portugal, Cancer Genetics Group, Research Centre of the Portuguese Oncology Institute-Porto, Porto, Portugal, Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway, Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, Porto, Portugal

    X
  • Published: November 19, 2012
  • DOI: 10.1371/journal.pone.0049819

Viewed info

Cited info

Saved info

Discussed info

Questions or concerns about usage data? Please let us know.